Company Filing History:
Years Active: 1993
Title: The Innovations of Makoto Shiozaki
Introduction
Makoto Shiozaki is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of hypoglycemic agents. His work focuses on innovative methods to reduce blood sugar levels, which is crucial for managing diabetes.
Latest Patents
Shiozaki holds a patent for a method of reducing blood sugar levels using a hypoglycemic agent. The patent details pharmaceutical compositions containing the polypeptides BUF-3, BUF-4, and BUF-5, which exhibit hypoglycemic activity. BUF-3 is identified as a homodimer of monomer A, while BUF-4 is a heterodimer of monomer A and monomer B. These polypeptides can be produced through cell culture of malignant leukemia cells or by recombinant DNA engineering. He has 1 patent to his name.
Career Highlights
Makoto Shiozaki is associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work at Ajinomoto has allowed him to explore and develop innovative solutions in the pharmaceutical industry.
Collaborations
Shiozaki has collaborated with notable colleagues such as Yasuo Totsuka and Itaru Kojima. Their combined expertise has contributed to advancements in their respective fields.
Conclusion
Makoto Shiozaki's contributions to the pharmaceutical industry, particularly in developing hypoglycemic agents, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the field and offers promising solutions for diabetes management.